{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:34:55Z","timestamp":1793316895239,"version":"4.5.0"},"reference-count":334,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","translationalres.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.trsl.2020.05.006","type":"journal-article","created":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T11:45:02Z","timestamp":1590234302000},"page":"105-130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":104,"special_numbering":"C","title":["Microvascular thrombosis: experimental and clinical implications"],"prefix":"10.1016","volume":"225","author":[{"given":"Monica A.","family":"Bray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Sartain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jahnavi","family":"Gollamudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolando E.","family":"Rumbaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2020.05.006_bib0001","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1182\/blood-2018-11-882993","article-title":"Thromboinflammation: challenges of therapeutically targeting coagulation and other host defense mechanisms","volume":"133","author":"Jackson","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2020.05.006_bib0002","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0952-7915(01)00302-8","article-title":"The molecular basis of innate immunity in the horseshoe crab","volume":"14","author":"Iwanaga","year":"2002","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0003","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1182\/blood-2009-05-199208","article-title":"Coagulation and innate immune responses: can we view them separately","volume":"114","author":"Delvaeye","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2020.05.006_bib0004","doi-asserted-by":"crossref","unstructured":"Johnson PC.Overview of the microcirculation: microcirculation2008; 11-24.","DOI":"10.1016\/B978-0-12-374530-9.00022-X"},{"key":"10.1016\/j.trsl.2020.05.006_bib0005","first-page":"H1958","article-title":"Dilator response of rat mesenteric arcading arterioles to increased blood flow velocity","volume":"257","author":"Smiesko","year":"1989","journal-title":"Am J Physiol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0006","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nm0603-685","article-title":"Molecular regulation of vessel maturation","volume":"9","author":"Jain","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.trsl.2020.05.006_bib0007","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0034-5687(78)90104-4","article-title":"The normal human lung: ultrastructure and morphometric estimation of diffusion capacity","volume":"32","author":"Gehr","year":"1978","journal-title":"Respir Physiol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0008","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1152\/japplphysiol.00013.2019","article-title":"Adolph distinguished lecture. contemporary model of muscle microcirculation: gateway to function and dysfunction","volume":"127","author":"Poole","year":"2019","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0009","first-page":"43","article-title":"Fine structure of the human skeletal muscle capillary. A morphometric analysis.","volume":"7","author":"Gidlof","year":"1988","journal-title":"Int J Microcirc Clin Exp."},{"key":"10.1016\/j.trsl.2020.05.006_bib0010","first-page":"174","article-title":"Phenotypic heterogeneity of the endothelium: II","volume":"100","author":"Aird","year":"2007","journal-title":"Representative vascular beds. Circ Res."},{"key":"10.1016\/j.trsl.2020.05.006_bib0011","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1161\/01.RES.0000255691.76142.4a","article-title":"Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms","volume":"100","author":"Aird","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.trsl.2020.05.006_bib0012","doi-asserted-by":"crossref","first-page":"23618","DOI":"10.1073\/pnas.1912409116","article-title":"The in vivo endothelial cell translatome is highly heterogeneous across vascular beds","volume":"116","author":"Cleuren","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trsl.2020.05.006_bib0013","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.isci.2018.05.003","article-title":"Human organ-specific endothelial cell heterogeneity","volume":"4","author":"Marcu","year":"2018","journal-title":"iScience"},{"key":"10.1016\/j.trsl.2020.05.006_bib0014","first-page":"1","article-title":"Interspecific scaling of blood flow rates and arterial sizes in mammals","volume":"222","author":"Seymour","year":"2019","journal-title":"J Exp Biol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0015","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s11517-008-0330-2","article-title":"Wall shear stress as measured in vivo: consequences for the design of the arterial system","volume":"46","author":"Reneman","year":"2008","journal-title":"Med Biol Eng Comput"},{"key":"10.1016\/j.trsl.2020.05.006_bib0016","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1161\/01.RES.77.5.1017","article-title":"Design principles of vascular beds","volume":"77","author":"Pries","year":"1995","journal-title":"Circ Res"},{"key":"10.1016\/j.trsl.2020.05.006_bib0017","first-page":"L61","article-title":"Endothelial gaps and permeability of venules in rat tracheas exposed to inflammatory stimuli","volume":"266","author":"McDonald","year":"1994","journal-title":"Am J Physiol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0018","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1152\/physrev.1995.75.3.519","article-title":"Flow-mediated endothelial mechanotransduction","volume":"75","author":"Davies","year":"1995","journal-title":"Physiol Rev"},{"key":"10.1016\/j.trsl.2020.05.006_bib0019","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.cmpb.2015.12.016","article-title":"Pulsatile magneto-hydrodynamic blood flows through porous blood vessels using a third grade non-Newtonian fluids model","volume":"126","author":"Akbarzadeh","year":"2016","journal-title":"Comput Methods Programs Biomed"},{"key":"10.1016\/j.trsl.2020.05.006_bib0020","first-page":"H2229","article-title":"Determination of capillary tube hematocrit during arteriolar microperfusion","volume":"266","author":"Keller","year":"1994","journal-title":"Am J Physiol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0021","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/micc.12141","article-title":"Non-Newtonian flow of blood in arterioles: consequences for wall shear stress measurements","volume":"21","author":"Sriram","year":"2014","journal-title":"Microcirculation"},{"key":"10.1016\/j.trsl.2020.05.006_bib0022","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006429","article-title":"Endothelial cell heterogeneity","volume":"2","author":"Aird","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.trsl.2020.05.006_bib0023","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3389\/fcvm.2020.00042","article-title":"Single cell analysis in vascular biology","volume":"7","author":"Chavkin","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.trsl.2020.05.006_bib0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/science.aal2379","article-title":"Organotypic vasculature: from descriptive heterogeneity to functional pathophysiology","volume":"357","author":"Augustin","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.trsl.2020.05.006_bib0025","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/10739680590925493","article-title":"Endogenous mechanisms of inhibition of platelet function","volume":"12","author":"Jin","year":"2005","journal-title":"Microcirculation"},{"key":"10.1016\/j.trsl.2020.05.006_bib0026","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1161\/CIRCRESAHA.115.305364","article-title":"The human microcirculation: regulation of flow and beyond","volume":"118","author":"Gutterman","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.trsl.2020.05.006_bib0027","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00424-007-0212-8","article-title":"The endothelial glycocalyx: composition, functions, and visualization","volume":"454","author":"Reitsma","year":"2007","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.trsl.2020.05.006_bib0028","article-title":"Integrated systems physiology: from molecule to function to disease. Platelet-vessel wall interactions in hemostasis and thrombosis","author":"Rumbaut","year":"2010","journal-title":"San Rafael Morgan Claypool Life Sci"},{"key":"10.1016\/j.trsl.2020.05.006_bib0029","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1161\/01.RES.0000065917.53950.75","article-title":"The endothelial glycocalyx protects against myocardial edema","volume":"92","author":"van den Berg","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.trsl.2020.05.006_bib0030","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.exer.2018.11.012","article-title":"Effect of diabetes and hyaluronidase on the retinal endothelial glycocalyx in mice","volume":"179","author":"Leskova","year":"2019","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.trsl.2020.05.006_bib0031","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/nm.2843","article-title":"The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis","volume":"18","author":"Schmidt","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.trsl.2020.05.006_bib0032","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1182\/blood.V88.5.1525.1525","article-title":"Platelets and shear stress","volume":"88","author":"Kroll","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2020.05.006_bib0033","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.bbrc.2007.01.137","article-title":"The role of endothelial glycocalyx components in mechanotransduction of fluid shear stress","volume":"355","author":"Pahakis","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.trsl.2020.05.006_bib0034","doi-asserted-by":"crossref","first-page":"H485","DOI":"10.1152\/ajpheart.00035.2016","article-title":"Fluid shear stress induces upregulation of COX-2 and PGI2 release in endothelial cells via a pathway involving PECAM-1, PI3K, FAK, and p38","volume":"312","author":"Russell-Puleri","year":"2017","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0035","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bpj.2017.05.033","article-title":"Endothelial glycocalyx-mediated nitric oxide production in response to selective AFM pulling","volume":"113","author":"Bartosch","year":"2017","journal-title":"Biophys J"},{"key":"10.1016\/j.trsl.2020.05.006_bib0036","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1161\/01.CIR.101.13.1500","article-title":"Oxidized lipoproteins degrade the endothelial surface layer: implications for platelet-endothelial cell adhesion","volume":"101","author":"Vink","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.trsl.2020.05.006_bib0037","first-page":"H2272","article-title":"Microvascular blood flow resistance: role of endothelial surface layer","volume":"273","author":"Pries","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0038","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1093\/cvr\/cvy167","article-title":"A disintegrin and metalloproteinase 15-mediated glycocalyx shedding contributes to vascular leakage during inflammation","volume":"114","author":"Yang","year":"2018","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.trsl.2020.05.006_bib0039","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/cvr\/cvp097","article-title":"Antithrombin reduces shedding of the endothelial glycocalyx following ischaemia\/reperfusion","volume":"83","author":"Chappell","year":"2009","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.trsl.2020.05.006_bib0040","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jcrc.2018.06.015","article-title":"Glycocalyx biomarker syndecan-1 is a stronger predictor of respiratory failure in patients with sepsis due to pneumonia, compared to endocan","volume":"47","author":"Smart","year":"2018","journal-title":"J Crit Care"},{"key":"10.1016\/j.trsl.2020.05.006_bib0041","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1172\/JCI124485","article-title":"Circulating heparan sulfate fragments mediate septic cognitive dysfunction","volume":"129","author":"Hippensteel","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2020.05.006_bib0042","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.clinbiochem.2016.02.014","article-title":"Evolution of serum hyaluronan and syndecan levels in prognosis of sepsis patients","volume":"49","author":"Anand","year":"2016","journal-title":"Clin Biochem"},{"key":"10.1016\/j.trsl.2020.05.006_bib0043","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/jth.14371","article-title":"Derangement of the endothelial glycocalyx in sepsis","volume":"17","author":"Iba","year":"2019","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.trsl.2020.05.006_bib0044","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1164\/rccm.201511-2281OC","article-title":"Urinary glycosaminoglycans predict outcomes in septic shock and acute respiratory distress syndrome","volume":"194","author":"Schmidt","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.trsl.2020.05.006_bib0045","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jcrc.2017.07.049","article-title":"Circulating syndecan-1 predicts the development of disseminated intravascular coagulation in patients with sepsis","volume":"43","author":"Ikeda","year":"2018","journal-title":"J Crit Care"},{"key":"10.1016\/j.trsl.2020.05.006_bib0046","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13054-018-2292-6","article-title":"The glycocalyx: a novel diagnostic and therapeutic target in sepsis","volume":"23","author":"Uchimido","year":"2019","journal-title":"Crit Care"},{"key":"10.1016\/j.trsl.2020.05.006_bib0047","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/288373a0","article-title":"The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine","volume":"288","author":"Furchgott","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2020.05.006_bib0048","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/327524a0","article-title":"Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor","volume":"327","author":"Palmer","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2020.05.006_bib0049","doi-asserted-by":"crossref","first-page":"4561","DOI":"10.1007\/s00018-015-2021-0","article-title":"Endothelial nitric oxide synthase in the microcirculation","volume":"72","author":"Shu","year":"2015","journal-title":"Cell Mol Life Sci"},{"issue":"Suppl I","key":"10.1016\/j.trsl.2020.05.006_bib0050","first-page":"55","article-title":"Endothelial regulation of coronary microvascular tone under physiological and pathophysiological conditions","volume":"14","author":"Chilian","year":"1993","journal-title":"Eur Heart J"},{"key":"10.1016\/j.trsl.2020.05.006_bib0051","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001274","article-title":"Loss of function in heparan sulfate elongation genes EXT1 and EXT 2 results in improved nitric oxide bioavailability and endothelial function","volume":"3","author":"Mooij","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.trsl.2020.05.006_bib0052","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0092-8674(03)00803-1","article-title":"Nitric oxide regulates exocytosis by S-nitrosylation of N-ethylmaleimide-sensitive factor","volume":"115","author":"Matsushita","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.trsl.2020.05.006_bib0053","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1161\/01.ATV.18.1.139","article-title":"Endogenous nitric oxide protects against thromboembolism in venules but not in arterioles","volume":"18","author":"Broeders","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0054","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1161\/01.CIR.86.4.1302","article-title":"Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries","volume":"86","author":"Yao","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.trsl.2020.05.006_bib0055","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.2353\/ajpath.2010.090316","article-title":"Endothelial von Willebrand factor release due to eNOS deficiency predisposes to thrombotic microangiopathy in mouse aging kidney","volume":"176","author":"Nakayama","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0056","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1053\/j.ajkd.2010.06.006","article-title":"The role of endothelial cell injury in thrombotic microangiopathy","volume":"56","author":"Goldberg","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.trsl.2020.05.006_bib0057","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1167\/iovs.04-0806","article-title":"Pulsatile flow increases the expression of eNOS, ET-1, and prostacyclin in a novel in vitro coculture model of the retinal vasculature","volume":"46","author":"Walshe","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.trsl.2020.05.006_bib0058","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1476-5381.1978.tb07809.x","article-title":"Prostacyclin (PGI2) inhibits the formation of platelet thrombi in arterioles and venules of the hamster cheek pouch","volume":"63","author":"Higgs","year":"1978","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0059","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1161\/01.ATV.21.1.163","article-title":"Endogenous nitric oxide and prostaglandins synergistically counteract thromboembolism in arterioles but not in venules","volume":"21","author":"Broeders","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0060","doi-asserted-by":"crossref","first-page":"H3119","DOI":"10.1152\/ajpheart.00588.2006","article-title":"Exercise training enhances flow-induced vasodilation in skeletal muscle resistance arteries of aged rats: role of PGI2 and nitric oxide","volume":"292","author":"Spier","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0061","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.lfs.2010.10.017","article-title":"Inducible COX-2 dominates over COX-1 in prostacyclin biosynthesis: mechanisms of COX-2 inhibitor risk to heart disease","volume":"88","author":"Ruan","year":"2011","journal-title":"Life Sci"},{"key":"10.1016\/j.trsl.2020.05.006_bib0062","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1111\/j.1538-7836.2008.03133.x","article-title":"Aspirin and the in vitro linear relationship between thromboxane A2-mediated platelet aggregation and platelet production of thromboxane A2","volume":"6","author":"Armstrong","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.trsl.2020.05.006_bib0063","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1161\/CIRCRESAHA.119.314927","article-title":"Cell-specific gene deletion reveals the antithrombotic function of COX1 and explains the vascular COX1\/prostacyclin paradox","volume":"125","author":"Mitchell","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.trsl.2020.05.006_bib0064","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1113\/expphysiol.2007.038588","article-title":"Role of nitric oxide and prostacyclin as vasoactive hormones released by the endothelium","volume":"93","author":"Mitchell","year":"2008","journal-title":"Exp Physiol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0065","first-page":"659","article-title":"Tacrolimus (FK 506) induced thrombotic thrombocytopenic purpura after ABO mismatched second liver transplantation: salvage with plasmapheresis and prostacyclin","volume":"85","author":"Au","year":"2000","journal-title":"Haematologica"},{"key":"10.1016\/j.trsl.2020.05.006_bib0066","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0007-1226(96)90061-2","article-title":"Intravenous infusion of prostacyclin to prevent platelet thrombus during microvascular anastomoses","volume":"49","author":"Gateley","year":"1996","journal-title":"Br J Plast Surg"},{"key":"10.1016\/j.trsl.2020.05.006_bib0067","first-page":"1329","article-title":"Unsuccessful treatment of resistant thrombotic thrombocytopenic purpura with prostacyclin","volume":"85","author":"Salvi","year":"2000","journal-title":"Haematologica"},{"key":"10.1016\/j.trsl.2020.05.006_bib0068","doi-asserted-by":"crossref","first-page":"33116","DOI":"10.1074\/jbc.271.51.33116","article-title":"Identification and characterization of CD39\/vascular ATP diphosphohydrolase","volume":"271","author":"Kaczmarek","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2020.05.006_bib0069","doi-asserted-by":"crossref","first-page":"262","DOI":"10.2741\/3926","article-title":"Tissue factor pathway inhibitor: structure-function","volume":"17","author":"Broze","year":"2012","journal-title":"Front Biosci (Landmark Ed)"},{"key":"10.1016\/j.trsl.2020.05.006_bib0070","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1172\/JCI31027","article-title":"Crucial role of the protein C pathway in governing microvascular inflammation in inflammatory bowel disease","volume":"117","author":"Scaldaferri","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2020.05.006_bib0071","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1021\/bi00169a024","article-title":"Endogenous antithrombin associated with microvascular endothelium. Quantitative analysis in perfused rat hearts","volume":"33","author":"Felsch","year":"1994","journal-title":"Biochemistry."},{"key":"10.1016\/j.trsl.2020.05.006_bib0072","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1001\/jama.290.2.238","article-title":"Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial","volume":"290","author":"Abraham","year":"2003","journal-title":"Jama"},{"key":"10.1016\/j.trsl.2020.05.006_bib0073","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1056\/NEJMoa1202290","article-title":"Drotrecogin alfa (activated) in adults with septic shock","volume":"366","author":"Ranieri","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2020.05.006_bib0074","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1001\/jama.286.15.1869","article-title":"Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial","volume":"286","author":"Warren","year":"2001","journal-title":"JAMA."},{"key":"10.1016\/j.trsl.2020.05.006_bib0075","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/jama.2019.5358","article-title":"Effect of a recombinant human soluble thrombomodulin on mortality in patients with sepsis-associated coagulopathy: the SCARLET randomized clinical trial","volume":"321","author":"Vincent","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.trsl.2020.05.006_bib0076","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jcm8111869","article-title":"A systematic summary of systematic reviews on anticoagulant therapy in sepsis","volume":"8","author":"Murao","year":"2019","journal-title":"J Clin Med"},{"issue":"Suppl 1","key":"10.1016\/j.trsl.2020.05.006_bib0077","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1016\/S0049-3848(08)70022-7","article-title":"Overview of murine thrombosis models","volume":"122","author":"Whinna","year":"2008","journal-title":"Thromb Res"},{"key":"10.1016\/j.trsl.2020.05.006_bib0078","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/10739680590925664","article-title":"Microvascular thrombosis models in venules and arterioles in vivo","volume":"12","author":"Rumbaut","year":"2005","journal-title":"Microcirculation"},{"key":"10.1016\/j.trsl.2020.05.006_bib0079","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/iep.12182","article-title":"New approaches in tail-bleeding assay in mice: improving an important method for designing new anti-thrombotic agents","volume":"97","author":"Saito","year":"2016","journal-title":"Int J Exp Pathol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0080","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/j.1538-7836.2009.03334.x","article-title":"Abnormal platelet function in C3-deficient mice","volume":"7","author":"Gushiken","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.trsl.2020.05.006_bib0081","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1182\/blood.2019001543","article-title":"Catalytic dysregulation of SHP2 leading to Noonan syndromes affects platelet signaling and functions","volume":"134","author":"Bellio","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2020.05.006_bib0082","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/10739680601139294","article-title":"Both ADP and thrombin regulate arteriolar thrombus stabilization and embolization, but are not involved in initial hemostasis as induced by micropuncture","volume":"14","author":"van Gestel","year":"2007","journal-title":"Microcirculation"},{"key":"10.1016\/j.trsl.2020.05.006_bib0083","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0049-3848(76)90032-3","article-title":"The effect ofinhibition of prostaglandin synthesis on microvascular haemostasis and macromolecular leakage","volume":"8","author":"Arfors","year":"1976","journal-title":"Thromb Res"},{"key":"10.1016\/j.trsl.2020.05.006_bib0084","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1159\/000067208","article-title":"Real-time detection of activation patterns in individual platelets during thromboembolism in vivo: differences between thrombus growth and embolus formation","volume":"39","author":"van Gestel","year":"2002","journal-title":"J Vasc Res"},{"key":"10.1016\/j.trsl.2020.05.006_bib0085","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0090-6980(84)90111-4","article-title":"Prostaglandin endoperoxides and thromboxane A2 in thrombus formation in the hamster cheek pouch in vivo","volume":"28","author":"Lewis","year":"1984","journal-title":"Prostaglandins"},{"key":"10.1016\/j.trsl.2020.05.006_bib0086","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0021-5198(19)52664-6","article-title":"A study on the in vivo production ofthrombosis in rat mesenteric arterioles and action of prostaglandin (PG) I2 on the thrombosis","volume":"32","author":"Takano","year":"1982","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0087","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/0026-2862(73)90011-3","article-title":"Experimental thrombus formation in mesenteric microvessels: evaluation of a method","volume":"6","author":"Gordon","year":"1973","journal-title":"Microvasc Res"},{"key":"10.1016\/j.trsl.2020.05.006_bib0088","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1177\/000331976501600807","article-title":"A comparison of vascular smooth muscle reactivity, thrombus formation and fragility in response to electrical stimuli in the hamster cheek pouch and mesocaecum","volume":"16","author":"Brooks","year":"1965","journal-title":"Angiology"},{"key":"10.1016\/j.trsl.2020.05.006_bib0089","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1538-7836.2009.03666.x","article-title":"Arterial thrombosis: relevance of a model with two levels of severity assessed by histologic, ultrastructural and functional characterization","volume":"8","author":"Hechler","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.trsl.2020.05.006_bib0090","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/10739680490425949","article-title":"Mouse cremaster venules are predisposed to light\/dye-induced thrombosis independent of wall shear rate, CD18, ICAM-1, or P-selectin","volume":"11","author":"Rumbaut","year":"2004","journal-title":"Microcirculation"},{"key":"10.1016\/j.trsl.2020.05.006_bib0091","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1111\/jth.14291","article-title":"Protein disulfide isomerase regulation by nitric oxide maintains vascular quiescence and controls thrombus formation","volume":"16","author":"Bekendam","year":"2018","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.trsl.2020.05.006_bib0092","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1182\/blood-2016-12-755587","article-title":"The disulfide isomerase ERp72 supports arterial thrombosis in mice","volume":"130","author":"Zhou","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2020.05.006_bib0093","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1161\/ATVBAHA.116.308050","article-title":"12(S)-HETrE, a 12-Lipoxygenase oxylipin of dihomo-gamma-linolenic acid, inhibits thrombosis via galphas signaling in platelets","volume":"36","author":"Yeung","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0094","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1161\/CIRCULATIONAHA.118.039345","article-title":"Novel role for the AnxA1-Fpr2\/ALX signaling axis as a key regulator of platelet function to promote resolution of inflammation","volume":"140","author":"Senchenkova","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.trsl.2020.05.006_bib0095","doi-asserted-by":"crossref","first-page":"34230","DOI":"10.1074\/jbc.M113.504928","article-title":"RhoG protein regulates glycoprotein VI-Fc receptor gamma-chain complex-mediated platelet activation and thrombus formation","volume":"288","author":"Kim","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2020.05.006_bib0096","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1161\/ATVBAHA.108.175679","article-title":"Differential role of vonWillebrand factor and P-selectin on microvascular thrombosis in endotoxemia","volume":"28","author":"Patel","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0097","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1160\/TH04-05-0308","article-title":"Dysfunctional platelet membrane receptors: from humans to mice","volume":"92","author":"Ware","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.trsl.2020.05.006_bib0098","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1182\/blood-2011-03-339705","article-title":"Genome-wide RNA-seq analysis of human and mouse platelet transcriptomes","volume":"118","author":"Rowley","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2020.05.006_bib0099","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.4049\/jimmunol.172.5.2731","article-title":"Of mice and not men: differences between mouse and human immunology","volume":"172","author":"Mestas","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0100","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ni.2631","article-title":"Nucleation of platelets with blood-borne pathogens on Kupffer cells precedes other innate immunity and contributes to bacterial clearance","volume":"14","author":"Wong","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0101","doi-asserted-by":"crossref","first-page":"6673","DOI":"10.1038\/ncomms7673","article-title":"Molecular mechanisms of NET formation and degradation revealed by intravital imaging in the liver vasculature","volume":"6","author":"Kolaczkowska","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.trsl.2020.05.006_bib0102","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.redox.2012.11.001","article-title":"Ferric chloride-induced murine carotid arterial injury: a model of redox pathology","volume":"1","author":"Li","year":"2013","journal-title":"Redox Biol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0103","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0049-3848(90)90106-M","article-title":"Rat model of arterial thrombosis induced by ferric chloride","volume":"60","author":"Kurz","year":"1990","journal-title":"Thromb Res"},{"key":"10.1016\/j.trsl.2020.05.006_bib0104","doi-asserted-by":"crossref","unstructured":"Bonnard T, Hagemeyer CE.Ferric chloride-induced thrombosis mouse model on carotid artery and mesentery vessel. J Vis Exp. 2015:e52838.","DOI":"10.3791\/52838-v"},{"key":"10.1016\/j.trsl.2020.05.006_bib0105","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1161\/CIRCRESAHA.118.314571","article-title":"Plasma peptidylarginine deiminase IV promotes VWF-platelet string formation and accelerates thrombosis after vessel injury","volume":"125","author":"Sorvillo","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.trsl.2020.05.006_bib0106","doi-asserted-by":"crossref","first-page":"e71447","DOI":"10.1371\/journal.pone.0071447","article-title":"Cathepsin G-dependent modulation of platelet thrombus formation in vivo by blood neutrophils","volume":"8","author":"Faraday","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2020.05.006_bib0107","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1182\/blood-2015-02-628594","article-title":"Resolving the multifaceted mechanisms of the ferric chloride thrombosis model using an interdisciplinary microfluidic approach","volume":"126","author":"Ciciliano","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2020.05.006_bib0108","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1182\/blood-2012-11-468983","article-title":"Red blood cells mediate the onset of thrombosis in the ferric chloride murine model","volume":"121","author":"Barr","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2020.05.006_bib0109","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1182\/blood.V96.10.3322","article-title":"Platelets adhere to and translocate on von Willebrand factor presented by endothelium in stimulated veins","volume":"96","author":"Andre","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2020.05.006_bib0110","doi-asserted-by":"crossref","first-page":"13824","DOI":"10.1038\/srep13824","article-title":"Inhibitory effect of caffeic acid on ADP-induced thrombus formation and platelet activation involves mitogen-activated protein kinases","volume":"5","author":"Lu","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.trsl.2020.05.006_bib0111","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.thromres.2015.02.033","article-title":"A recombinant fragment of von Willebrand factor reduces fibrin-rich microthrombi formation in mice with endotoxemia","volume":"135","author":"Nguyen","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.trsl.2020.05.006_bib0112","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1161\/ATVBAHA.119.312848","article-title":"Formation and resolution of pial microvascular thrombosis in a mouse model of thrombotic thrombocytopenic purpura","volume":"39","author":"Adili","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0113","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1093\/ndt\/gfm774","article-title":"A murine model of site-specific renal microvascular endothelial injury and thrombotic microangiopathy","volume":"23","author":"Hohenstein","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trsl.2020.05.006_bib0114","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/jth.13986","article-title":"Platelet packing density is an independent regulator of the hemostatic response to injury","volume":"16","author":"Mirramezani","year":"2018","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.trsl.2020.05.006_bib0115","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1182\/blood-2015-09-672188","article-title":"A systems approach to hemostasis: 4. How hemostatic thrombi limit the loss of plasma-borne molecules from the microvasculature","volume":"127","author":"Welsh","year":"2016","journal-title":"Blood."},{"key":"10.1016\/j.trsl.2020.05.006_bib0116","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0224434","article-title":"Serial block-face scanning electron microscopy reveals neuronal-epithelial cell fusion in the mouse cornea","volume":"14","author":"Courson","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2020.05.006_bib0117","doi-asserted-by":"crossref","first-page":"834","DOI":"10.5858\/2003-127-834-TTPAHU","article-title":"Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome are distinct pathologic entities. A review of 56 autopsy cases","volume":"127","author":"Hosler","year":"2003","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.trsl.2020.05.006_bib0118","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/BF00694889","article-title":"Immunohistochemical study on the liver in autopsy cases with disseminated intravascular coagulation (DIC) with reference to clinicopathological analysis","volume":"404","author":"Esaki","year":"1984","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0119","doi-asserted-by":"crossref","first-page":"5112","DOI":"10.1038\/s41598-020-59526-x","article-title":"The distinctive structure and composition of arterial and venous thrombi and pulmonary emboli","volume":"10","author":"Chernysh","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.trsl.2020.05.006_bib0120","doi-asserted-by":"crossref","DOI":"10.1177\/1756286418785071","article-title":"Primary angiitis of the central nervous system: diagnosis and treatment","volume":"11","author":"Beuker","year":"2018","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.trsl.2020.05.006_bib0121","first-page":"307","article-title":"Association of capillaroscopic microhaemorrhages with clinical and immunological antiphospholipid syndrome","volume":"29","author":"Aslanidis","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0122","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s13075-017-1354-5","article-title":"The cumulative number of micro-haemorrhages and micro-thromboses in nailfold videocapillaroscopy is a good indicator of disease activity in systemic sclerosis: a validation study of the NEMO score","volume":"19","author":"Andracco","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.trsl.2020.05.006_bib0123","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.mayocp.2016.05.015","article-title":"Thrombotic microangiopathy care pathway: a consensus statement for the Mayo Clinic Complement Alternative Pathway-Thrombotic Microangiopathy (CAP-TMA) Disease-Oriented Group","volume":"91","author":"Go","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.trsl.2020.05.006_bib0124","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1182\/blood.V35.1.104.104","article-title":"The production of schistocytes by fibrin strands (a scanning electron microscope study)","volume":"35","author":"Bull","year":"1970","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2020.05.006_bib0125","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1182\/asheducation-2017.1.632","article-title":"Plasma exchange in thrombotic microangiopathies (TMAs) other than thrombotic thrombocytopenic purpura (TTP)","volume":"2017","author":"Winters","year":"2017","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.trsl.2020.05.006_bib0126","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jca.21705","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice - evidence-based approach from the writing committee of the American Society for Apheresis: The eighth special issue","volume":"34","author":"Padmanabhan","year":"2019","journal-title":"J Clin Apher"},{"key":"10.1016\/j.trsl.2020.05.006_bib0127","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1055\/s-0032-1328886","article-title":"Drug-associated thrombotic microangiopathies","volume":"38","author":"Kreuter","year":"2012","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.trsl.2020.05.006_bib0128","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0140-6736(11)61145-8","article-title":"Management of an acute outbreak of diarrhoea-associated haemolytic uraemic syndrome with early plasma exchange in adults from southern Denmark: an observational study","volume":"378","author":"Colic","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.trsl.2020.05.006_bib0129","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2141.2012.09167.x","article-title":"Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies","volume":"158","author":"Scully","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0130","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1160\/TH08-12-0825","article-title":"Heterogeneous pathogenic processes of thrombotic microangiopathies in patients with connective tissue diseases","volume":"102","author":"Matsuyama","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.trsl.2020.05.006_bib0131","doi-asserted-by":"crossref","first-page":"7899","DOI":"10.1073\/pnas.0608422104","article-title":"Shear-induced unfolding triggers adhesion of von Willebrand factor fibers","volume":"104","author":"Schneider","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trsl.2020.05.006_bib0132","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12185-009-0476-1","article-title":"Pathophysiology of thrombotic thrombocytopenic purpura","volume":"91","author":"Tsai","year":"2010","journal-title":"Int J Hematol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0133","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1182\/blood-2002-05-1401","article-title":"ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions","volume":"100","author":"Dong","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2020.05.006_bib0134","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1056\/NEJMcp053024","article-title":"Clinical practice. Thrombotic thrombocytopenic purpura","volume":"354","author":"George","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2020.05.006_bib0135","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1055\/s-0037-1614327","article-title":"Transcriptional expression of tissue factor pathway inhibitor, thrombomodulin and von Willebrand factor in normal human tissues","volume":"82","author":"Bajaj","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.trsl.2020.05.006_bib0136","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1182\/blood.V92.8.2791","article-title":"Tissue distribution and regulation of murine von Willebrand factor gene expression in vivo","volume":"92","author":"Yamamoto","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2020.05.006_bib0137","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/brainsci10010031","article-title":"Differential expression of CD31 and Von Willebrand Factor on endothelial cells in different regions of the human brain: potential implications for cerebral malaria pathogenesis","volume":"10","author":"Mbagwu","year":"2020","journal-title":"Brain Sci"},{"key":"10.1016\/j.trsl.2020.05.006_bib0138","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1016\/S2352-3026(17)30026-1","article-title":"Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study","volume":"4","author":"Bendapudi","year":"2017","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0139","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/CCM.0b013e31822e9d66","article-title":"Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center","volume":"40","author":"Froissart","year":"2012","journal-title":"Crit Care Med."},{"key":"10.1016\/j.trsl.2020.05.006_bib0140","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1182\/blood-2011-03-341131","article-title":"A phase 2 study of the safety and efficacy of rituximab with plasma exchange in acute acquired thrombotic thrombocytopenic purpura","volume":"118","author":"Scully","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2020.05.006_bib0141","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa1806311","article-title":"Caplacizumab treatment for acquired thrombotic thrombocytopenic purpura","volume":"380","author":"Scully","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2020.05.006_bib0142","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1309\/AJCP5BVL4FCLCGLU","article-title":"Thrombotic microangiopathic hemolytic anemia with reduction of ADAMTS13 activity: initial manifestation of childhood-onset systemic lupus erythematosus","volume":"135","author":"Muscal","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0143","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/humu.21143","article-title":"ADAMTS13 mutations and polymorphisms in congenital thrombotic thrombocytopenic purpura","volume":"31","author":"Lotta","year":"2010","journal-title":"Hum Mutat"},{"key":"10.1016\/j.trsl.2020.05.006_bib0144","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1182\/blood-2017-06-788026","article-title":"Recombinant ADAMTS-13: first-in-human pharmacokinetics and safety in congenital thrombotic thrombocytopenic purpura","volume":"130","author":"Scully","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2020.05.006_bib0145","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3324\/haematol.10262","article-title":"Acquired ADAMTS-13 deficiency in pediatric patients with severe sepsis","volume":"92","author":"Nguyen","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.trsl.2020.05.006_bib0146","doi-asserted-by":"crossref","first-page":"E49","DOI":"10.25011\/cim.v40i2.28195","article-title":"Prognostic value of ADAMTS13 in patients with severe sepsis and septic shock","volume":"40","author":"Azfar","year":"2017","journal-title":"Clin Invest Med"},{"key":"10.1016\/j.trsl.2020.05.006_bib0147","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/rheumatology\/keq395","article-title":"Microangiopathic haemolytic anaemia resembling thrombotic thrombocytopenic purpura in systemic lupus erythematosus: the role of ADAMTS13","volume":"50","author":"Lansigan","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.trsl.2020.05.006_bib0148","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1111\/trf.13654","article-title":"Treatment with or without plasma exchange for patients with acquired thrombotic microangiopathy not associated with severe ADAMTS13 deficiency: a propensity score-matched study","volume":"56","author":"Li","year":"2016","journal-title":"Transfusion"},{"key":"10.1016\/j.trsl.2020.05.006_bib0149","doi-asserted-by":"crossref","first-page":"7195","DOI":"10.1074\/jbc.RA118.002639","article-title":"Brain microvascular endothelial cells exhibit lower activation of the alternative complement pathway than glomerular microvascular endothelial cells","volume":"293","author":"Sartain","year":"2018","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2020.05.006_bib0150","doi-asserted-by":"crossref","first-page":"832","DOI":"10.4049\/jimmunol.1500960","article-title":"TNF regulates essential alternative complement pathway components and impairs activation of protein C in human glomerular endothelial cells","volume":"196","author":"Sartain","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0151","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1056\/NEJMoa0810739","article-title":"Thrombomodulin mutations in atypical hemolytic-uremic syndrome","volume":"361","author":"Delvaeye","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2020.05.006_bib0152","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000187761","article-title":"Verotoxin-binding in human renal sections","volume":"66","author":"Lingwood","year":"1994","journal-title":"Nephron"},{"key":"10.1016\/j.trsl.2020.05.006_bib0153","first-page":"1073","article-title":"Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome","volume":"365","author":"Tarr","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.trsl.2020.05.006_bib0154","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1007\/s00467-018-3903-9","article-title":"Eculizumab treatment in severe pediatric STEC-HUS: a multicenter retrospective study","volume":"33","author":"Percheron","year":"2018","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0155","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1056\/NEJM200006293422601","article-title":"The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections","volume":"342","author":"Wong","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2020.05.006_bib0156","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/S0140-6736(77)92915-4","article-title":"Thomsen-Friedenreich antigen in haemolytic-uraemic syndrome","volume":"2","author":"Klein","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/j.trsl.2020.05.006_bib0157","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF00852894","article-title":"Haemolytic uraemic syndrome and the Thomsen Friedenreich antigen","volume":"3","author":"McGraw","year":"1989","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0158","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jpeds.2007.04.057","article-title":"Hemolytic uremic syndrome and streptococcus pneumoniae: improving our understanding","volume":"151","author":"Geary","year":"2007","journal-title":"J Pediatr"},{"key":"10.1016\/j.trsl.2020.05.006_bib0159","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1182\/asheducation-2018.1.382","article-title":"Autoimmune hemolytic anemia","volume":"2018","author":"Hill","year":"2018","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.trsl.2020.05.006_bib0160","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrneph.2016.70","article-title":"Complement in disease: a defence system turning offensive","volume":"12","author":"Ricklin","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0161","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2215\/CJN.02210310","article-title":"Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype","volume":"5","author":"Noris","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0162","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1055\/s-0034-1375701","article-title":"Pathology of renal diseases associated with dysfunction of the alternative pathway of complement: C3 glomerulopathy and atypical hemolytic uremic syndrome (aHUS)","volume":"40","author":"Sethi","year":"2014","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.trsl.2020.05.006_bib0163","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.4049\/jimmunol.1201751","article-title":"Tissue-specific host recognition by complement factor H is mediated by differential activities of its glycosaminoglycan-binding regions","volume":"190","author":"Clark","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0164","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1681\/ASN.2013050453","article-title":"Comprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome","volume":"25","author":"Bu","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0165","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.mayocp.2018.07.008","article-title":"Diagnostic utility of complement serology for atypical hemolytic uremic syndrome","volume":"93","author":"Sridharan","year":"2018","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.trsl.2020.05.006_bib0166","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.kint.2015.11.026","article-title":"Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome","volume":"89","author":"Greenbaum","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.trsl.2020.05.006_bib0167","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1053\/j.ajkd.2015.12.034","article-title":"Terminal complement inhibitor eculizumab in adult patients with atypical hemolytic uremic syndrome: a single-arm, open-label trial","volume":"68","author":"Fakhouri","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.trsl.2020.05.006_bib0168","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.tmrv.2019.09.004","article-title":"Eculizumab and beyond: the past, present, and future of complement therapeutics","volume":"33","author":"Patriquin","year":"2019","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.trsl.2020.05.006_bib0169","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1084\/jem.20020077","article-title":"The lectin-like domain of thrombomodulin confers protection from neutrophil-mediated tissue damage by suppressing adhesion molecule expression via nuclear factor kappaB and mitogen-activated protein kinase pathways","volume":"196","author":"Conway","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.trsl.2020.05.006_bib0170","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/ng.2590","article-title":"Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome","volume":"45","author":"Lemaire","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.trsl.2020.05.006_bib0171","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.blre.2014.09.001","article-title":"De novo thrombotic microangiopathy after non-renal solid organ transplantation","volume":"28","author":"Verbiest","year":"2014","journal-title":"Blood Rev"},{"key":"10.1016\/j.trsl.2020.05.006_bib0172","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.bbmt.2006.11.020","article-title":"Transplant-associated microangiopathy in patients receiving tacrolimus following allogeneic stem cell transplantation: risk factors and response to treatment","volume":"13","author":"Oran","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.trsl.2020.05.006_bib0173","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/1076029615598221","article-title":"Hematopoietic stem cell transplant-associated thrombotic microangiopathy","volume":"22","author":"Elsallabi","year":"2016","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.trsl.2020.05.006_bib0174","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1182\/blood-2014-03-564997","article-title":"Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults","volume":"124","author":"Jodele","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2020.05.006_bib0175","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/BF02983218","article-title":"Clinical significance of fragmented red cells after allogeneic bone marrow transplantation","volume":"77","author":"Kanamori","year":"2003","journal-title":"Int J Hematol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0176","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1537-2995.2004.00700.x","article-title":"Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: a diagnostic dilemma","volume":"44","author":"George","year":"2004","journal-title":"Transfusion"},{"key":"10.1016\/j.trsl.2020.05.006_bib0177","doi-asserted-by":"crossref","first-page":"e28070","DOI":"10.1002\/pbc.28070","article-title":"The alternative complement pathway activation product Ba as a marker for transplant-associated thrombotic microangiopathy","volume":"67","author":"Sartain","year":"2020","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.trsl.2020.05.006_bib0178","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1182\/blood-2013-05-501445","article-title":"Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy","volume":"122","author":"Jodele","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2020.05.006_bib0179","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbmt.2018.08.016","article-title":"Therapeutic plasma exchange does not improve renal function in hematopoietic stem cell transplantation-associated thrombotic microangiopathy: an institutional experience","volume":"25","author":"Sartain","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.trsl.2020.05.006_bib0180","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.bbmt.2013.12.565","article-title":"Eculizumab therapy in children with severe hematopoietic stem cell transplantation-associated thrombotic microangiopathy","volume":"20","author":"Jodele","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.trsl.2020.05.006_bib0181","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1016\/j.bbmt.2017.08.019","article-title":"Thrombotic microangiopathy after allogeneic stem cell transplantation: a comparison of eculizumab therapy and conventional therapy","volume":"23","author":"Bohl","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.trsl.2020.05.006_bib0182","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1182\/blood-2014-11-611335","article-title":"Drug-induced thrombotic microangiopathy: a systematic review of published reports","volume":"125","author":"Al-Nouri","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2020.05.006_bib0183","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/hep.22130","article-title":"Liver disease in pregnancy","volume":"47","author":"Hay","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.trsl.2020.05.006_bib0184","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/GRF.0000000000000253","article-title":"Diagnosis and management of HELLP syndrome complicated by liver hematoma","volume":"60","author":"Ditisheim","year":"2017","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0185","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/0002-9378(92)91735-S","article-title":"Hepatic histopathologic condition does not correlate with laboratory abnormalities in HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count)","volume":"167","author":"Barton","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0186","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1097\/01.ogx.0000146948.19308.c5","article-title":"HELLP syndrome: the state of the art","volume":"59","author":"Baxter","year":"2004","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.trsl.2020.05.006_bib0187","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1053\/j.ackd.2013.01.001","article-title":"Emerging new biomarkers of preeclampsia","volume":"20","author":"Polsani","year":"2013","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.trsl.2020.05.006_bib0188","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3109\/10641955.2013.806538","volume":"32","author":"Simsek","year":"2013","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.trsl.2020.05.006_bib0189","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.exphem.2016.01.005","article-title":"Direct evidence of complement activation in HELLP syndrome: a link to atypical hemolytic uremic syndrome","volume":"44","author":"Vaught","year":"2016","journal-title":"Exp Hematol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0190","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1097\/00007611-200093080-00005","article-title":"Leukocytosis is proportional to HELLP syndrome severity: evidence for an inflammatory form of preeclampsia","volume":"93","author":"Terrone","year":"2000","journal-title":"South Med J"},{"key":"10.1016\/j.trsl.2020.05.006_bib0191","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.99128","article-title":"Germline mutations in the alternative pathway of complement predispose to HELLP syndrome","volume":"3","author":"Vaught","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.trsl.2020.05.006_bib0192","doi-asserted-by":"crossref","first-page":"4542","DOI":"10.1182\/blood-2008-03-144691","article-title":"Factor H, membrane cofactor protein, and factor I mutations in patients with hemolysis, elevated liver enzymes, and low platelet count syndrome","volume":"112","author":"Fakhouri","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2020.05.006_bib0193","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1365-2141.2008.07324.x","article-title":"Advances in understanding of pathogenesis of aHUS and HELLP","volume":"143","author":"Fang","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0194","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1097\/01.AOG.0000126245.35811.2a","article-title":"Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count","volume":"103","author":"Sibai","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0195","first-page":"1122","article-title":"Task force on hypertension in P. hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy","volume":"122","year":"2013","journal-title":"Obstet Gynecol."},{"key":"10.1016\/j.trsl.2020.05.006_bib0196","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/10641950802174953","article-title":"HELLP syndrome is associated with an increased inflammatory response, which may be inhibited by administration of prednisolone","volume":"27","author":"van Runnard Heimel","year":"2008","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.trsl.2020.05.006_bib0197","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008148.pub2","article-title":"Corticosteroids for HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome in pregnancy","author":"Woudstra","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.trsl.2020.05.006_bib0198","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2018-228709","article-title":"Eculizumab, a novel potential treatment for acute kidney injury associated with preeclampsia\/HELLP syndrome","volume":"12","author":"Elabd","year":"2019","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.trsl.2020.05.006_bib0199","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/ijlh.12168","article-title":"Schistocytes in disseminated intravascular coagulation","volume":"36","author":"Lesesve","year":"2014","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0200","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S0022-3476(71)80222-6","article-title":"Coagulation findings in the hemolytic-uremic syndrome of infancy: similarity to hyperacute renal allograft rejection","volume":"78","author":"Katz","year":"1971","journal-title":"J Pediatr"},{"key":"10.1016\/j.trsl.2020.05.006_bib0201","doi-asserted-by":"crossref","first-page":"353","DOI":"10.5551\/jat.49494","article-title":"Profiles of coagulation and fibrinolysis activation-associated molecular markers of atypical hemolytic uremic syndrome in the acute phase","volume":"27","author":"Sakurai","year":"2019","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.trsl.2020.05.006_bib0202","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1055\/s-0037-1616068","article-title":"Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation","volume":"86","author":"Taylor","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.trsl.2020.05.006_bib0203","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/2052-0492-2-15","article-title":"Diagnosis and treatment of disseminated intravascular coagulation (DIC) according to four DIC guidelines","volume":"2","author":"Wada","year":"2014","journal-title":"J Intensive Care"},{"key":"10.1016\/j.trsl.2020.05.006_bib0204","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.trsl.2020.05.006_bib0205","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02553-18","article-title":"Protease-mediated growth of staphylococcus aureus on host proteins is opp3 dependent","volume":"10","author":"Lehman","year":"2019","journal-title":"mBio."},{"key":"10.1016\/j.trsl.2020.05.006_bib0206","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158293","article-title":"Contribution of staphylococcus aureus coagulases and clumping factor A to abscess formation in a rabbit model of skin and soft tissue infection","volume":"11","author":"Malachowa","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2020.05.006_bib0207","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1097\/CCM.0b013e3181c98d21","article-title":"Inflammation and coagulation","volume":"38","author":"Levi","year":"2010","journal-title":"Crit Care Med"},{"key":"10.1016\/j.trsl.2020.05.006_bib0208","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.tcm.2015.12.001","article-title":"Tissue factor as a link between inflammation and coagulation","volume":"26","author":"Witkowski","year":"2016","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.trsl.2020.05.006_bib0209","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/08830185.2016.1261318","article-title":"Pathogen recognition and Toll-like receptor targeted therapeutics in innate immune cells","volume":"36","author":"Tartey","year":"2017","journal-title":"Int Rev Immunol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0210","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMra021333","article-title":"The pathophysiology and treatment of sepsis","volume":"348","author":"Hotchkiss","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2020.05.006_bib0211","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1097\/PCC.0000000000002105","article-title":"A multicenter network assessment of three inflammation phenotypes in pediatric sepsis-induced multiple organ failure","volume":"20","author":"Carcillo","year":"2019","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.trsl.2020.05.006_bib0212","doi-asserted-by":"crossref","first-page":"16037","DOI":"10.1038\/nrdp.2016.37","article-title":"Disseminated intravascular coagulation","volume":"2","author":"Gando","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.trsl.2020.05.006_bib0213","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1080\/17474086.2018.1500173","article-title":"Disseminated intravascular coagulation: an update on pathogenesis and diagnosis","volume":"11","author":"Levi","year":"2018","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0214","first-page":"1087","article-title":"Selective cellular expression of tissue factor in human tissues","volume":"134","author":"Drake","year":"1989","journal-title":"Implications for disorders of hemostasis and thrombosis. Am J Pathol."},{"key":"10.1016\/j.trsl.2020.05.006_bib0215","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0049-3848(90)90148-6","article-title":"Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody","volume":"59","author":"Fleck","year":"1990","journal-title":"Thromb Res"},{"key":"10.1016\/j.trsl.2020.05.006_bib0216","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1161\/ATVBAHA.117.309846","article-title":"Tissue factor: an essential mediator of hemostasis and trigger of thrombosis","volume":"38","author":"Grover","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0217","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1182\/blood.V96.2.554.014k17_554_559","article-title":"The in vivo kinetics of tissue factor messenger RNA expression during human endotoxemia: relationship with activation of coagulation","volume":"96","author":"Franco","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2020.05.006_bib0218","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1080\/09537104.2019.1624708","article-title":"Detection of tissue factor in platelets: why is it so troublesome?","volume":"30","author":"Osterud","year":"2019","journal-title":"Platelets"},{"key":"10.1016\/j.trsl.2020.05.006_bib0219","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.vph.2014.05.005","article-title":"Regulation of tissue factor gene expression in monocytes and endothelial cells: thromboxane A2 as a new player","volume":"62","author":"Bode","year":"2014","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0220","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.molmed.2014.01.007","article-title":"Why have clinical trials in sepsis failed?","volume":"20","author":"Marshall","year":"2014","journal-title":"Trends Mol Med."},{"key":"10.1016\/j.trsl.2020.05.006_bib0221","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12964-018-0235-0","article-title":"Neutrophil extracellular traps induce aggregation of washed human platelets independently of extracellular DNA and histones","volume":"16","author":"Elaskalani","year":"2018","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.trsl.2020.05.006_bib0222","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.thromres.2013.04.018","article-title":"Histone induced platelet aggregation is inhibited by normal albumin","volume":"132","author":"Lam","year":"2013","journal-title":"Thromb Res"},{"key":"10.1016\/j.trsl.2020.05.006_bib0223","doi-asserted-by":"crossref","first-page":"e277","DOI":"10.3324\/haematol.2015.140632","article-title":"Histones stimulate von Willebrand factor release in vitro and in vivo","volume":"101","author":"Lam","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.trsl.2020.05.006_bib0224","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1161\/ATVBAHA.114.304114","article-title":"Neutrophil extracellular traps promote thrombin generation through platelet-dependent and platelet-independent mechanisms","volume":"34","author":"Gould","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0225","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.blre.2015.12.004","article-title":"DAMP and DIC: the role of extracellular DNA and DNA-binding proteins in the pathogenesis of DIC","volume":"30","author":"Liaw","year":"2016","journal-title":"Blood Rev"},{"key":"10.1016\/j.trsl.2020.05.006_bib0226","doi-asserted-by":"crossref","first-page":"15880","DOI":"10.1073\/pnas.1005743107","article-title":"Extracellular DNA traps promote thrombosis","volume":"107","author":"Fuchs","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trsl.2020.05.006_bib0227","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1161\/ATVBAHA.113.303016","article-title":"von Willebrand factor directly interacts with DNA from neutrophil extracellular traps","volume":"34","author":"Grassle","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0228","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nm.2184","article-title":"Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases","volume":"16","author":"Massberg","year":"2010","journal-title":"Nat Med"},{"key":"10.1016\/j.trsl.2020.05.006_bib0229","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/nri.2017.105","article-title":"Neutrophil extracellular traps in immunity and disease","volume":"18","author":"Papayannopoulos","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0230","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1084\/jem.20112322","article-title":"Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo","volume":"209","author":"von Bruhl","year":"2012","journal-title":"J Exp Med"},{"key":"10.1016\/j.trsl.2020.05.006_bib0231","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1538-7836.2011.04544.x","article-title":"Neutrophil extracellular traps promote deep vein thrombosis in mice","volume":"10","author":"Brill","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.trsl.2020.05.006_bib0232","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1126\/science.aam8897","article-title":"Host DNases prevent vascular occlusion by neutrophil extracellular traps","volume":"358","author":"Jimenez-Alcazar","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.trsl.2020.05.006_bib0233","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/00000658-199901000-00016","article-title":"Disseminated intravascular coagulation and sustained systemic inflammatory response syndrome predict organ dysfunctions after trauma: application of clinical decision analysis","volume":"229","author":"Gando","year":"1999","journal-title":"Ann Surg"},{"key":"10.1016\/j.trsl.2020.05.006_bib0234","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.injury.2004.12.037","article-title":"Pathophysiology of polytrauma","volume":"36","author":"Keel","year":"2005","journal-title":"Injury"},{"key":"10.1016\/j.trsl.2020.05.006_bib0235","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/emm.2007.47","article-title":"Toll-like receptor signal transduction","volume":"39","author":"Krishnan","year":"2007","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.trsl.2020.05.006_bib0236","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nature08780","article-title":"Circulating mitochondrial DAMPs cause inflammatory responses to injury","volume":"464","author":"Zhang","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2020.05.006_bib0237","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ccc.2016.08.006","article-title":"Postinjury inflammation and organ dysfunction","volume":"33","author":"Sauaia","year":"2017","journal-title":"Crit Care Clin"},{"key":"10.1016\/j.trsl.2020.05.006_bib0238","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1056\/NEJM197405092901903","article-title":"Defibrination after brain-tissue destruction: a serious complication of head injury","volume":"290","author":"Goodnight","year":"1974","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2020.05.006_bib0239","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1055\/s-0037-1615025","article-title":"Significant correlations between tissue factor and thrombin markers in trauma and septic patients with disseminated intravascular coagulation","volume":"79","author":"Gando","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.trsl.2020.05.006_bib0240","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/00005373-199910000-00017","article-title":"Systemic activation of tissue-factor dependent coagulation pathway in evolving acute respiratory distress syndrome in patients with trauma and sepsis","volume":"47","author":"Gando","year":"1999","journal-title":"J Trauma"},{"key":"10.1016\/j.trsl.2020.05.006_bib0241","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/2052-0492-2-20","article-title":"Classifying types of disseminated intravascular coagulation: clinical and animal models","volume":"2","author":"Asakura","year":"2014","journal-title":"J Intensive Care"},{"key":"10.1016\/j.trsl.2020.05.006_bib0242","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-2141.2004.04844.x","article-title":"Plasminogen activator inhibitor 1 (PAI-1): in vitro activities and clinical relevance","volume":"125","author":"Horrevoets","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0243","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1042\/cs0880587","article-title":"Plasminogen activator and plasminogen activator inhibitor I release during experimental endotoxaemia in chimpanzees: effect of interventions in the cytokine and coagulation cascades","volume":"88","author":"Biemond","year":"1995","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.trsl.2020.05.006_bib0244","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/jth.12190","article-title":"Differentiating disseminated intravascular coagulation (DIC) with the fibrinolytic phenotype from coagulopathy of trauma and acute coagulopathy of trauma-shock (COT\/ACOTS)","volume":"11","author":"Gando","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.trsl.2020.05.006_bib0245","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/PL00002452","article-title":"Therapeutical strategies and outcome of polytraumatized patients with pelvic injuries: a six-year experience","volume":"26","author":"Ertel","year":"2000","journal-title":"Eur J Trauma"},{"key":"10.1016\/j.trsl.2020.05.006_bib0246","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.1182\/blood-2012-01-402156","article-title":"Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreatic cancer","volume":"119","author":"Wang","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2020.05.006_bib0247","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nm0296-209","article-title":"In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease","volume":"2","author":"Contrino","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.trsl.2020.05.006_bib0248","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1055\/s-0037-1616139","article-title":"Disseminated intravascular coagulation in solid tumors: clinical and pathologic study","volume":"86","author":"Sallah","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.trsl.2020.05.006_bib0333","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1182\/blood-2017-03-743211","article-title":"Cancer-associated pathways and biomarkers of venous thrombosis","volume":"130","author":"Hisada","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2020.05.006_bib0249","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1136\/adc.2009.176610","article-title":"Review of haemophagocytic lymphohistiocytosis","volume":"96","author":"Freeman","year":"2011","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.trsl.2020.05.006_bib0250","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.trsl.2020.05.006_bib0251","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001692","article-title":"Coagulation disorders and bleedings in critically Ill patients with hemophagocytic lymphohistiocytosis","volume":"94","author":"Valade","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.trsl.2020.05.006_bib0252","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1080\/15513819609168681","article-title":"Histopathology of the liver in histiocytosis syndromes","volume":"16","author":"Favara","year":"1996","journal-title":"Pediatr Pathol Lab Med"},{"key":"10.1016\/j.trsl.2020.05.006_bib0253","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1097\/PAS.0b013e3181dbbb17","article-title":"Pathology of the liver in familial hemophagocytic lymphohistiocytosis","volume":"34","author":"Chen","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0254","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/pbc.21423","article-title":"Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis","volume":"50","author":"Allen","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.trsl.2020.05.006_bib0255","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1182\/blood-2017-06-788349","article-title":"Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study","volume":"130","author":"Bergsten","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2020.05.006_bib0256","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1002\/art.38802","article-title":"Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients","volume":"66","author":"Minoia","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0257","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMoa1911326","article-title":"Emapalumab in children with primary hemophagocytic lymphohistiocytosis","volume":"382","author":"emapLocatelli","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2020.05.006_bib0258","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12969-015-0055-3","article-title":"Evidence-based diagnosis and treatment of macrophage activation syndrome in systemic juvenile idiopathic arthritis","volume":"13","author":"Boom","year":"2015","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.trsl.2020.05.006_bib0259","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/art.41103","article-title":"Benefit of anakinra in treating pediatric secondary hemophagocytic lymphohistiocytosis","volume":"72","author":"Eloseily","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0260","doi-asserted-by":"crossref","first-page":"R297","DOI":"10.1186\/cc13163","article-title":"A randomized, controlled, multicenter trial of the effects of antithrombin on disseminated intravascular coagulation in patients with sepsis","volume":"17","author":"Gando","year":"2013","journal-title":"Crit Care"},{"key":"10.1016\/j.trsl.2020.05.006_bib0261","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1007\/BF02982120","article-title":"A comparative double-blind randomized trial of activated protein C and unfractionated heparin in the treatment of disseminated intravascular coagulation","volume":"75","author":"Aoki","year":"2002","journal-title":"Int J Hematol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0262","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jcm8101553","article-title":"Human soluble recombinant thrombomodulin, ART-123, resolved early phase coagulopathies, but did not significantly alter the 28 day outcome in the treatment of DIC associated with infectious systemic inflammatory response syndromes","volume":"8","author":"Mori","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.trsl.2020.05.006_bib0263","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1164\/rccm.200612-1803OC","article-title":"Prophylactic heparin in patients with severe sepsis treated with drotrecogin alfa (activated)","volume":"176","author":"Levi","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.trsl.2020.05.006_bib0264","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1160\/TH15-09-0740","article-title":"Supportive management strategies for disseminated intravascular coagulation. An international consensus","volume":"115","author":"Squizzato","year":"2016","journal-title":"Thromb Haemost."},{"key":"10.1016\/j.trsl.2020.05.006_bib0265","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.trsl.2020.05.006_bib0266","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/ncprheum0069","article-title":"Catastrophic antiphospholipid syndrome","volume":"2","author":"Merrill","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0267","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/17474086.2017.1300522","article-title":"Diagnosis and management of catastrophic antiphospholipid syndrome","volume":"10","author":"Carmi","year":"2017","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0268","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1538-7836.2009.03674.x","article-title":"Clinical course of high-risk patients diagnosed with antiphospholipid syndrome","volume":"8","author":"Pengo","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.trsl.2020.05.006_bib0269","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrrheum.2011.52","article-title":"Pathogenesis of antiphospholipid syndrome: understanding the antibodies","volume":"7","author":"Meroni","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0270","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1161\/01.CIR.94.7.1746","article-title":"Thrombogenic properties of murine anti-cardiolipin antibodies induced by beta 2 glycoprotein 1 and human immunoglobulin G antiphospholipid antibodies","volume":"94","author":"Pierangeli","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.trsl.2020.05.006_bib0271","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1182\/blood-2002-05-1310","article-title":"Thrombogenicity of beta 2-glycoprotein I-dependent antiphospholipid antibodies in a photochemically induced thrombosis model in the hamster","volume":"101","author":"Jankowski","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2020.05.006_bib0272","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1172\/JCI39828","article-title":"Antiphospholipid antibodies promote leukocyte-endothelial cell adhesion and thrombosis in mice by antagonizing eNOS via beta2GPI and apoER2","volume":"121","author":"Ramesh","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2020.05.006_bib0273","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1182\/blood.2019003863","article-title":"Complement activity and complement regulatory gene mutations are associated with thrombosis in APS and CAPS","volume":"135","author":"Chaturvedi","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2020.05.006_bib0274","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/key082","article-title":"The effect of triple therapy on the mortality of catastrophic anti-phospholipid syndrome patients","author":"Rodriguez-Pinto","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.trsl.2020.05.006_bib0275","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.autrev.2013.05.004","article-title":"Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab","volume":"12","author":"Berman","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.trsl.2020.05.006_bib0276","doi-asserted-by":"crossref","first-page":"527","DOI":"10.14639\/0392-100X-1188","article-title":"Free flap loss caused by heparin-induced thrombocytopenia and thrombosis (HITT): a case report and literature review","volume":"36","author":"Segna","year":"2016","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"10.1016\/j.trsl.2020.05.006_bib0277","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1378\/chest.127.5.1857","article-title":"Heparin-induced skin lesions and other unusual sequelae of the heparin-induced thrombocytopenia syndrome: a nested cohort study","volume":"127","author":"Warkentin","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.trsl.2020.05.006_bib0278","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1182\/blood-2012-07-443051","article-title":"Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis","volume":"120","author":"Cuker","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2020.05.006_bib0279","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1182\/bloodadvances.2018024489","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia","volume":"2","author":"Cuker","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.trsl.2020.05.006_bib0280","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1182\/blood.V98.8.2442","article-title":"Heparin-induced thrombocytopenia\/thrombosis in a transgenic mouse model requires human platelet factor 4 and platelet activation through FcgammaRIIA","volume":"98","author":"Reilly","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2020.05.006_bib0281","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1182\/blood.V84.11.3691.bloodjournal84113691","article-title":"Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia","volume":"84","author":"Warkentin","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2020.05.006_bib0282","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1182\/blood-2010-03-274969","article-title":"PRT-060318, a novel Syk inhibitor, prevents heparin-induced thrombocytopenia and thrombosis in a transgenic mouse model","volume":"117","author":"Reilly","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2020.05.006_bib0283","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1111\/j.1538-7836.2011.04470.x","article-title":"The Syk-kinase inhibitor R406 impairs platelet activation and monocyte tissue factor expression triggered by heparin-PF4 complex directed antibodies","volume":"9","author":"Lhermusier","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.trsl.2020.05.006_bib0284","doi-asserted-by":"crossref","first-page":"5467","DOI":"10.1016\/S0021-9258(18)42789-5","article-title":"Activation of Fc gamma RII induces tyrosine phosphorylation of multiple proteins including Fc gamma RII","volume":"267","author":"Huang","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2020.05.006_bib0285","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/s41467-019-09160-7","article-title":"Neutrophil activation and NETosis are the major drivers of thrombosis in heparin-induced thrombocytopenia","volume":"10","author":"Perdomo","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.trsl.2020.05.006_bib0286","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/jci.insight.99445","article-title":"Neutrophil accumulation and NET release contribute to thrombosis in HIT","volume":"3","author":"Gollomp","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.trsl.2020.05.006_bib0287","doi-asserted-by":"crossref","DOI":"10.1378\/chest.11-2303","article-title":"Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Linkins","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.trsl.2020.05.006_bib0288","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1111\/jth.13813","article-title":"Autoimmune heparin-induced thrombocytopenia","volume":"15","author":"Greinacher","year":"2017","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.trsl.2020.05.006_bib0289","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1213\/00000539-198605000-00018","article-title":"Heparin-associated thrombocytopenia: alternative managements","volume":"65","author":"Vender","year":"1986","journal-title":"Anesth Analg"},{"key":"10.1016\/j.trsl.2020.05.006_bib0290","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1213\/ANE.0b013e3181c3c1cd","article-title":"Plasmapheresis and heparin reexposure as a management strategy for cardiac surgical patients with heparin-induced thrombocytopenia","volume":"110","author":"Welsby","year":"2010","journal-title":"Anesth Analg"},{"key":"10.1016\/j.trsl.2020.05.006_bib0334","doi-asserted-by":"crossref","DOI":"10.1016\/j.trsl.2020.04.014","article-title":"Pathogenesis of heparin-induced thrombocytopenia","author":"Arepally","year":"2020","journal-title":"Transl Res"},{"key":"10.1016\/j.trsl.2020.05.006_bib0291","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1056\/NEJM199709113371107","article-title":"Pathogenesis and treatment of sickle cell disease","volume":"337","author":"Bunn","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2020.05.006_bib0292","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1146\/annurev-pathmechdis-012418-012838","article-title":"Pathophysiology of sickle cell disease","volume":"14","author":"Sundd","year":"2019","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0293","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1182\/blood-2007-07-089144","article-title":"Treatment and prevention of pain due to vaso-occlusive crises in adults with sickle cell disease: an educational void","volume":"111","author":"Solomon","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2020.05.006_bib0294","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1146\/annurev-bioeng-070909-105339","article-title":"Sickle cell biomechanics","volume":"12","author":"Barabino","year":"2010","journal-title":"Annu Rev Biomed Eng"},{"key":"10.1016\/j.trsl.2020.05.006_bib0295","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1073\/pnas.052522799","article-title":"Primary role for adherent leukocytes in sickle cell vascular occlusion: a new paradigm","volume":"99","author":"Turhan","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trsl.2020.05.006_bib0296","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1126\/science.3603036","article-title":"Delay time of hemoglobin S polymerization prevents most cells from sickling in vivo","volume":"237","author":"Mozzarelli","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.trsl.2020.05.006_bib0297","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1073\/pnas.1424111112","article-title":"Kinetics of sickle cell biorheology and implications for painful vasoocclusive crisis","volume":"112","author":"Du","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trsl.2020.05.006_bib0298","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/ajh.10145","article-title":"Sickle erythrocyte adherence to endothelium at low shear: role of shear stress in propagation of vaso-occlusion","volume":"70","author":"Montes","year":"2002","journal-title":"Am J Hematol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0299","doi-asserted-by":"crossref","first-page":"7173","DOI":"10.1038\/srep07173","article-title":"Heterogeneous red blood cell adhesion and deformability in sickle cell disease","volume":"4","author":"Alapan","year":"2014","journal-title":"Sci Rep"},{"key":"10.1016\/j.trsl.2020.05.006_bib0300","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/10739680802279394","article-title":"Sickle red cell-endothelium interactions","volume":"16","author":"Kaul","year":"2009","journal-title":"Microcirculation"},{"key":"10.1016\/j.trsl.2020.05.006_bib0301","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1182\/blood-2006-12-061697","article-title":"Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobin","volume":"110","author":"Villagra","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2020.05.006_bib0302","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1182\/blood-2011-02-272682","article-title":"Silent cerebral infarcts: a review on a prevalent and progressive cause of neurologic injury in sickle cell anemia","volume":"119","author":"DeBaun","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2020.05.006_bib0303","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1172\/JCI72305","article-title":"Neutrophil AKT2 regulates heterotypic cell-cell interactions during vascular inflammation","volume":"124","author":"Li","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2020.05.006_bib0304","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1182\/blood-2015-09-618538","article-title":"Neutrophils, platelets, and inflammatory pathways at the nexus of sickle cell disease pathophysiology","volume":"127","author":"Zhang","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2020.05.006_bib0305","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1182\/blood-2004-02-0713","article-title":"The contribution of endothelial cell P-selectin to the microvascular flow of mouse sickle erythrocytes in vivo","volume":"104","author":"Embury","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2020.05.006_bib0306","doi-asserted-by":"crossref","first-page":"H2715","DOI":"10.1152\/ajpheart.00986.2004","article-title":"Critical role of endothelial cell activation in hypoxia-induced vasoocclusion in transgenic sickle mice","volume":"288","author":"Belcher","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0307","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1182\/blood-2014-03-563874","article-title":"Erythroid DAMPs drive inflammation in SCD","volume":"123","author":"Gladwin","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2020.05.006_bib0308","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1182\/blood-2013-04-495887","article-title":"Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease","volume":"123","author":"Belcher","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2020.05.006_bib0309","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/bjh.12336","article-title":"Interplay between coagulation and vascular inflammation in sickle cell disease","volume":"162","author":"Sparkenbaugh","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0310","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1111\/trf.12700","article-title":"Heme-related molecules induce rapid production of neutrophil extracellular traps","volume":"54","author":"Kono","year":"2014","journal-title":"Transfusion"},{"key":"10.1016\/j.trsl.2020.05.006_bib0311","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1182\/blood.V99.11.4160","article-title":"Neutrophil activation by heme: implications for inflammatory processes","volume":"99","author":"Graca-Souza","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2020.05.006_bib0312","doi-asserted-by":"crossref","first-page":"E4110","DOI":"10.1073\/pnas.1405023111","article-title":"Hemolysis-induced lethality involves inflammasome activation by heme","volume":"111","author":"Dutra","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trsl.2020.05.006_bib0313","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.5858\/2001-125-1436-PTAIPW","article-title":"Pulmonary thrombotic arteriopathy in patients with sickle cell disease","volume":"125","author":"Adedeji","year":"2001","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.trsl.2020.05.006_bib0314","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0022-3476(05)80897-2","article-title":"Stroke in a cohort of patients with homozygous sickle cell disease","volume":"120","author":"Balkaran","year":"1992","journal-title":"J Pediatr"},{"key":"10.1016\/j.trsl.2020.05.006_bib0315","doi-asserted-by":"crossref","first-page":"e89761","DOI":"10.1172\/jci.insight.89761","article-title":"Lung vaso-occlusion in sickle cell disease mediated by arteriolar neutrophil-platelet microemboli","volume":"2","author":"Bennewitz","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.trsl.2020.05.006_bib0316","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1177\/082585970502100403","article-title":"Physicians' attitude and practices in sickle cell disease pain management","volume":"21","author":"Labbe","year":"2005","journal-title":"J Palliat Care"},{"key":"10.1016\/j.trsl.2020.05.006_bib0317","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1182\/blood-2012-02-409524","article-title":"Hydroxyurea and a cGMP-amplifying agent have immediate benefits on acute vaso-occlusive events in sickle cell disease mice","volume":"120","author":"Almeida","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2020.05.006_bib0318","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1053\/j.seminhematol.2018.04.007","article-title":"Novel sickle cell disease therapies: targeting pathways downstream of sickling","volume":"55","author":"Morrone","year":"2018","journal-title":"Semin Hematol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0319","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJMoa1903212","article-title":"A phase 3 randomized trial of voxelotor in sickle cell disease","volume":"381","author":"Vichinsky","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2020.05.006_bib0320","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1182\/blood-2014-06-583351","article-title":"Randomized phase 2 study of GMI-1070 in SCD: reduction in time to resolution of vaso-occlusive events and decreased opioid use","volume":"125","author":"Telen","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2020.05.006_bib0321","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1096\/fj.15-278481","article-title":"MEK1\/2 inhibitors reverse acute vascular occlusion in mouse models of sickle cell disease","volume":"30","author":"Zhao","year":"2016","journal-title":"FASEB J"},{"key":"10.1016\/j.trsl.2020.05.006_bib0322","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1182\/blood-2007-03-079665","article-title":"Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease","volume":"110","author":"Bernaudin","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2020.05.006_bib0323","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1056\/NEJMoa1609677","article-title":"Gene therapy in a patient with sickle cell disease","volume":"376","author":"Ribeil","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2020.05.006_bib0324","first-page":"646","article-title":"Nervous system involvement in Degos disease","volume":"26","author":"Amato","year":"2005","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0325","doi-asserted-by":"crossref","first-page":"S481","DOI":"10.1542\/peds.2016-4206","article-title":"Pediatric malignant atrophic papulosis","volume":"141","author":"Huang","year":"2018","journal-title":"Pediatrics"},{"key":"10.1016\/j.trsl.2020.05.006_bib0326","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1309\/AJCP66QIMFARLZKI","article-title":"Degos disease: a C5b-9\/interferon-alpha-mediated endotheliopathy syndrome","volume":"135","author":"Magro","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0327","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10456-010-9192-y","article-title":"Treprostinil increases the number and angiogenic potential of endothelial progenitor cells in children with pulmonary hypertension","volume":"14","author":"Smadja","year":"2011","journal-title":"Angiogenesis"},{"key":"10.1016\/j.trsl.2020.05.006_bib0328","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/jmv.25801","article-title":"Tocilizumab treatment in COVID-19: a single center experience","volume":"92","author":"Luo","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/j.trsl.2020.05.006_bib0329","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Tang","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.trsl.2020.05.006_bib0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.trsl.2020.04.007","article-title":"Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases","author":"Magro","year":"2020","journal-title":"Transl Res"},{"key":"10.1016\/j.trsl.2020.05.006_bib0331","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.trsl.2020.05.006_bib0332","article-title":"Neutrophil extracellular traps in COVID-19","volume":"5","author":"Zuo","year":"2020","journal-title":"JCI Insight"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524420301080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524420301080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T12:42:43Z","timestamp":1761828163000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524420301080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":334,"alternative-id":["S1931524420301080"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2020.05.006","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microvascular thrombosis: experimental and clinical implications","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2020.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}